MAOB, monoamine oxidase B, 4129

N. diseases: 152; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease BEFREE The second main outcome was to evaluate the association between MAO-B VT in the PFC and duration of major depressive disorder illness. 30840042 2019
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease BEFREE Extra-virgin olive oils (EVOOs) obtained from 'Brava' and 'Mansa', varieties recently identified from Galicia (northwestern Spain), were selected for in vitro screening to evaluate their capacity to inhibit key enzymes involved in Alzheimer's disease (AD) (acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) and 5-lipoxygenase (5-LOX)), major depressive disorder (MDD) and Parkinson's disease (PD) (monoamine oxidases: <i>h</i>MAO-A and <i>h</i>MAO-B respectively). 29561824 2018
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease BEFREE Selegiline is an irreversible monoamine oxidase-B (MAO-B) inhibitor, and is widely used in the treatment of PD and major depression. 28515684 2017
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease PSYGENET Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect. 19657584 2009
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease BEFREE Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect. 19657584 2009
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 Biomarker disease PSYGENET Our data provide first suggestive evidence that the MAOB A644G SNP is involved in the outcome of treatment with mirtazapine or paroxetine in females with major depression. 17640790 2007
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.350 GeneticVariation disease BEFREE Our data provide first suggestive evidence that the MAOB A644G SNP is involved in the outcome of treatment with mirtazapine or paroxetine in females with major depression. 17640790 2007